COMPARISON OF PERSONALIZED AND STANDARD PROPHYLAXIS BASED ON OCTOCOG ALFA IN PEDIATRIC PATIENTS WITH HEMOPHILIA A

• Authors: Tomasz Tatara , Marta Dąbrowska-Bender , Aneta Duda-Zalewska , Anna Staniszewska , Magdalena Kurek
• Languages of publication: EN

Abstracts

EN

Comparison of personalized and standard prophylaxis prevention therapies based on octocog alfa in pediatric patients with hemophilia A. Studies on a general population (adults and children) demonstrate a statistically significant advantage of personalized prevention therapy over standard prophylaxis prevention therapy in terms of annual bleeding rate (ABR) and annual joint bleeding rate (AJBR) while studies on a pediatric population included insufficiently large populations, however, their results demonstrate a numerical advantage of personalized approach over standard prevention strategy prophylaxis regimen.

Keywords

EN

Hemophilia A; octocog alfa; prophylaxis

• Journal: Acta Poloniae Pharmaceutica - Drug Research
• Year: 2020
• Volume: 77
• Issue: 2
• Pages: 221-218

Dates

published

2020-04-29

Contributors

author

Tomasz Tatara

author

Marta Dąbrowska-Bender

author

Aneta Duda-Zalewska

author

Anna Staniszewska

author

Magdalena Kurek

Identifiers

DOI

10.32383/appdr/118739